Standard Chartered beats first-quarter profit expectations on strong growth in wealth management

Standard Chartered beats first-quarter profit expectations on strong growth in wealth management


Standard Chartered Plc bank branch in Hong Kong

Bloomberg | Bloomberg | Getty Images

Standard Chartered on Friday beat first-quarter profit expectations on the back of strong growth in its wealth management, global markets, and global banking businesses.

The bank’s reported profit before taxation for the three months ended in March was $2.103 billion, up from $1.91 billion in the same period a year ago.

Here are Standard Chartered’s first-quarter 2025 results compared with consensus estimates compiled by the bank.

  • Profit before tax: $2.103 billion vs. $1.905 billion
  • Underlying net interest income (NII): $2.796 billion vs. $2.796 billion

“We delivered a strong performance in the first quarter of 2025, with earnings per share up 19%, driven by double-digit income growth in Wealth Solutions, Global Markets and Global Banking,” Group Chief Executive Bill Winters said in a statement.

The bank’s Wealth Solutions division was a standout performer during the quarter, posting a 28% increase year-on-year in operating income.

Standard Chartered’s Global Markets business posted a 14% increase in operating income during the quarter, powered by strong growth in credit trading. The Global Banking division experienced a 17% increase in operating income.

The bank, however, booked a $219 million credit impairment charge in Q1, up 24% year-on-year, with the bulk stemming from its Wealth and Retail Banking division, where rising rates have begun to strain repayments in certain unsecured portfolios.

The earnings do not fully capture the impact of U.S. President Donald Trump’s tariffs, as the “reciprocal” tariffs announced in April were put on hold. However, levies on steel, aluminum and autos have been in effect since March.

Winters said that while the imposition of trade tariffs has increased global economic and geopolitical complexity, he was confident that the bank would continue to improve returns.

“Our presence in structurally high-growth markets across Asia, Africa and the Middle East is key to driving long-term sustainable value for our shareholders, and we remain focused on reinforcing these competitive advantages to drive future growth,” Winters said.

The set of earnings comes after Standard Chartered reported in February that annual profits in 2024 surged 18% on the back of record growth in its wealth unit and robust results from its markets division. The London-headquartered lender had called for a $1.5 billion share buyback after the full-year results were reported.

The bank is also currently undertaking a cost-saving initiative called “Fit for Growth,” which it rolled out in 2024. It aims to save roughly $1.5 billion over three years.

Just a few days earlier, Asia-focused rival bank HSBC announced a share buyback of up to $3 billion, which it aimed to complete before its 2025 interim results.



Source

Asia-Pacific markets set to rebound as Trump comments raise hopes of Iran war ending in weeks
World

Asia-Pacific markets set to rebound as Trump comments raise hopes of Iran war ending in weeks

IBARAKI, JAPAN – JUNE 17: Technicians at work in the clean room of the Fab Equipment at a semiconductor company, Renesas Technology Corp. on June 17, 2004 in Ibaraki, Japan. Renesas is the first company to produce semiconductor products from 300mm wafer in the world. (Photo by Koichi Kamoshida/Getty Images) Koichi Kamoshida | Getty Images […]

Read More
Stock futures are little changed after major averages post best session since May: Live updates
World

Stock futures are little changed after major averages post best session since May: Live updates

Traders work on the floor of the New York Stock Exchange (NYSE) on March 31, 2026 in New York City. Spencer Platt | Getty Images U.S. stock futures were little changed on Tuesday night after all three major indexes surged during the regular session on hopes that an end to the Iran war is in […]

Read More
How Ireland became dependent on big pharma — and the risks ahead
World

How Ireland became dependent on big pharma — and the risks ahead

In just 50 years, Ireland has become the world’s third largest exporter of pharmaceuticals, with medicines now making up about 20% of Ireland’s GDP. So how did Ireland become so tied to the pharma industry — and is that reliance at risk amid tariffs, patent cliffs and geopolitical tension? Ireland manufactures some of the world’s […]

Read More